Skip to main content
logo
Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
9.40
-0.98 (-9.44%)
Nov 2, 2026, 2:05 PM EST - Market open

Gossamer Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
53.2948.47114.7---
Revenue Growth
32.43%-57.74%----
Gross Profit
53.2948.47114.7---
Operating Income
-158.62-163.25-59.92-173.76-218.53-216.05
Net Income
-125.22-170.37-56.53-179.82-229.38-234
Earnings Per Share
-51.97-59.64-19.99-94.26-216.97-250.13
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
57.03136.93294.52296.43255.68325.22
Total Debt
40.07202.91202.88212.46225.74185.24
Net Cash (Debt)
16.96-65.9791.6483.9629.94139.98
Net Cash Growth
68.15%-9.14%180.44%-78.61%-57.44%
Net Cash Per Share
5.35-23.1032.4044.0128.32149.63

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-162.63-171.27-3.47-159.16-187.03-188.89
Capital Expenditures
--0.08---0.41-1.55
Free Cash Flow
-162.63-171.35-3.47-159.16-187.44-190.44
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-297.67%-336.81%-52.24%---
Pretax Margin
-235.17%-351.67%-48.50%---
Profit Margin
-235.00%-351.49%-49.28%---
FCF Margin
-305.19%-353.50%-3.02%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.1914.801.79---